Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA

Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

$Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )$

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )

Novel fusion proteins to target PD-L1 in HPV associated cancers

Dr James Gulley - Center for Cancer Research, Washington, USA

Novel fusion proteins to target PD-L1 in HPV associated cancers ( Dr James Gulley - Center for Cancer Research, Washington, USA )

Daratumumab in combination with carfilzomib and dexamethasone for relapsed...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )

Phase I study results of M7824 for patients with HPV associated cancers

Dr Julius Strauss - Center for Cancer Research, Washington, USA

Phase I study results of M7824 for patients with HPV associated cancers ( Dr Julius Strauss - Center for Cancer Research, Washington, USA )

Pancreatic survival improved with trial chemotherapy regimen after surgery

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

Aspirin combined with acid-reducing medicine offers moderate benefits in...

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic...

Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus ( Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland )

Pre-operative chemotherapy with radiation may help people with pancreatic...

Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands

Pre-operative chemotherapy with radiation may help people with pancreatic cancer live longer ( Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands )

Comment: Pancreatic cancer survival extended by over a year with chemotherapy...

Dr Andrew Epstein and Prof Richard Schilsky

Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal...

Dr Andrew Epstein and Prof Richard Schilsky

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals ( Dr Andrew Epstein and Prof Richard Schilsky )

More from ecancer